title: Regulation of endothelial barrier function by cyclic nucleotides: the role of phosphodiesterases.
abstract: The endothelium plays an important role in maintaining normal vascular function. Endothelial barrier dysfunction leading to increased permeability and vascular leakage is associated with several pathological conditions such as edema and sepsis. Thus, the development of drugs that improve endothelial barrier function is an active area of research. In this chapter, the current knowledge concerning the signaling pathways regulating endothelial barrier function is discussed with a focus on cyclic nucleotide second messengers (cAMP and cGMP) and cyclic nucleotide phosphodiesterases (PDEs). Both cAMP and cGMP have been shown to have differential effects on endothelial permeability in part due to the various effector molecules, crosstalk, and compartmentalization of cyclic nucleotide signaling. PDEs, by controlling the amplitude, duration, and localization of cyclic nucleotides, have been shown to play a critical role in regulating endothelial barrier function. Thus, PDEs are attractive drug targets for the treatment of disease states involving endothelial barrier dysfunction.
authors.affiliation: Department of Pharmacology, University of Washington School of Medicine, 1959 NE Pacific St., 357280, Seattle, WA 98195-7280, USA.
authors.forename: James
authors.initials: J
authors.lastname: Surapisitchat
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Beavo
mesh_terms: D000818:Animals; D000242:Cyclic AMP / Q000502:physiology*; D006152:Cyclic GMP / Q000502:physiology*; D004730:Endothelium, Vascular / Q000378:metabolism*; D006801:Humans; D010539:Permeability; D010727:Phosphoric Diester Hydrolases / Q000502:physiology*; D015398:Signal Transduction
chemical_list: D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D006152:Cyclic GMP